Hong Kong researchers at CUHK are testing a surgical procedure for Alzheimer's, pioneered in mainland China, which has shown promise in improving patients' daily functions. The procedure was banned for unregulated use in mainland China due to safety concerns, prompting CUHK's controlled trials.
Scientists from Brain Chemistry Labs, in partnership with Calusa Waterkeeper, have identified airborne cyanobacterial neurotoxins, specifically 2,4-DAB, in Southwest Florida. This finding follows previous research linking the toxin to Alzheimer's in beached dolphins and suggests chronic human exposure, posing risks for neurodegenerative diseases like ALS.
Veteran radio DJ Paul Gambaccini has been diagnosed with Alzheimer's disease. The 77-year-old presenter for BBC Radio 2 and Greatest Hits Radio stated he will continue broadcasting and be open about his condition as it progresses.
Ett nytt blodprov som mäter alzheimermarkören p-tau217 kan upptäcka sjukdomen upp till 20 år före symtom. Testet används inom specialistsjukvården men rekommenderas inte för oroliga individer. Privata kliniker erbjuder testet, vilket oroar experter som menar att metoden missbrukas och att det saknas tydliga riktlinjer för positiva resultat.
A two-year clinical trial found that high-dose DHA supplements, while reaching the brain, did not improve memory or cognitive function in older adults at risk for Alzheimer's, nor did they slow brain atrophy. Researchers suggest enzyme disruption or chronic inflammation may blunt effects.
Wilford Lloyd Baumes, creatore della popolare serie televisiva "Love Boat" e sceneggiatore di "Wonder Woman", è deceduto serenamente il 28 giugno all'età di 86 anni. La sua carriera includeva anche la produzione di "Who Is the Black Dahlia?".
Actor Danny Glover, 79, revealed he has been living with Alzheimer's disease for several years. He shared his diagnosis, received "not long" after an honorary Oscar in 2022, to help reduce the stigma surrounding the condition.
Actor Danny Glover, 79, announced on The Today Show that he has been living with Alzheimer's for several years, diagnosed after receiving an honorary Oscar in 2022. He spoke about slowed movements, speech, and memory, but highlighted his family's support and his determination to continue living and working.
Eli Lilly's new Alzheimer's drug, donanemab (Lormalzi), has been approved in India to slow disease progression by clearing brain plaques. While offering potential benefits, experts express concerns about its high cost, the need for early diagnosis, and the extent of its real-world impact in India.
A Swiss study has identified a previously underestimated mechanism in Alzheimer's disease involving the protein GRK2 and developed a compound that may disrupt it. The research, published in Cell Reports Medicine, suggests that inactive GRK2 aggregates, attaches to mitochondria, and promotes beta-amyloid production, accelerating brain damage.
Jon Snow, 78, former lead presenter of Channel 4 News, reveals his Alzheimer's diagnosis in a new documentary, navigating prejudice and raising awareness alongside his wife Precious Lunga.
Taiwan has approved two new antibody drugs, lecanemab and donanemab, for Alzheimer's treatment. These drugs target and clear amyloid-beta plaques in the brain, aiming to slow cognitive decline, particularly in early stages. While effective, potential side effects like brain swelling or bleeding require regular MRI monitoring and genetic testing.
Alzheimer's is a growing global health crisis, affecting over 55 million worldwide. Italy faces significant challenges due to its aging population, with over 1.4 million affected. New therapies offer hope, but early diagnosis and organizational support are crucial. Technological innovations like the TEO robot are being developed to aid in monitoring and cognitive stimulation.
A study published in Neurology suggests that lifelong engagement in mentally stimulating activities like reading and learning new languages may reduce the risk of Alzheimer's disease by 38% and delay the onset of cognitive decline.
Researchers believe a simple blood test measuring pTau181 protein, combined with memory complaints, can detect Alzheimer's up to 30 years before diagnosis. This early detection could allow for preventative lifestyle changes or treatments to slow disease progression.
Biogen advances diranersen, an experimental tau-targeting Alzheimer's drug, to Phase 3 trials despite mixed mid-stage results, citing promising signals of tau reduction and slowed cognitive decline.
Eli Lilly prioritizes Alzheimer's in its innovation pipeline, launching Lormalzi (donanemab), a monthly amyloid-targeting therapy for early Alzheimer's, priced at ₹91,688 per vial in India.
An at-home test can help predict a person's risk of getting Alzheimer's, according to a new study.
Jordan and Cian Adams, the FTD Brothers from Redditch, ran the London Marathon carrying a 25kg fridge on their backs, raising almost £500,000 for Alzheimer's Research UK. Both brothers carry a gene giving them a 99% likelihood of developing frontotemporal dementia in their mid-to-late 40s, having lost their mother Geraldine to the condition in 2016. They plan to run 32 consecutive marathons across Ireland in 32 days, aiming to raise £550,000 and reach a total of £1m in memory of their mother, who was one of 12 relatives lost to FTD.
